Abstract: The invention relates to a hearing aid device for humans with impaired hearing, who have an at least partially functional cochlea and a functional nervous signalling pathway from the cochlea via the auditory nerve to the brain. The hearing aid device contains a receiver, a transducer of the sound or other acoustic signals into electrical current serving as a signal representing a sound, a pulsed irradiation source connected to the transducer for receiving the electrical current and for generating modulated pulsed irradiation in dependence from the electrical current, and preferably one or more optical fibers optically coupled to the exit of the pulsed irradiation source, wherein the optical path for conduction of irradiation within the device ends directly opposite a functional element of the natural vibration transduction pathway, e.g.

Abstract: The invention relates to a hearing aid device for humans with impaired hearing, who have an at least partially functional cochlea and a functional nervous signalling pathway from the cochlea via the auditory nerve to the brain. The hearing aid device contains a receiver, a transducer of the sound or other acoustic signals into electrical current serving as a signal representing a sound, a pulsed irradiation source connected to the transducer for receiving the electrical current and for generating modulated pulsed irradiation in dependence from the electrical current, and preferably one or more optical fibers optically coupled to the exit of the pulsed irradiation source, wherein the optical path for conduction of irradiation within the device ends directly opposite a functional element of the natural vibration transduction pathway, e.g.

Abstract: A device for adjusting and fixing relative position between an actuator end piece of an active hearing implant and an element of the ossicular chain or a coupling part to the human inner ear has a connecting element with a first coupling element for coupling to the actuator end piece, a second coupling element, and a shaft-shaped middle part, and the first coupling element geometrically encompasses the actuator end piece with two opposing parallel arms each having a pattern element to fix the encompassed actuator end piece in selectable discrete axial positions in a direction parallel to an axis of the shaft-shaped middle part, for variable-length adaptation and fixing of the actuator end piece relative to the first coupling element in a direction transverse to the axis.

Abstract: An electronic control device assists in the insertion of an implant into the body of a patient, and allows the implant to be arbitrarily altered in shape by applying control signals. Patient-specific geometric body data from a body region into which the implant is to be introduced is input and stored. Computer-aided simulation of the insertion operation uses the patient-specific body data as a basis for simulating the insertion operation to produce actuation data which control the arbitrary alteration in the shape of the implant. The control device outputs the actuation data to the implant in the form of control signals on the basis of a sensed or calculated current introduction position of the implant according to the prior simulation.

Abstract: An ossicular prosthesis is described which includes an elongated prosthesis member formed from a single foldable plane structure and having a proximal end and a distal end. A cochlear striker surface is located at the distal end of the prosthesis member for engaging an outer cochlear surface of a recipient patient.

Abstract: Drug delivery systems and biocompatible coatings for use with implantable stimulation devices such as cochlear implants have been developed. These drug delivery systems and coatings comprise polyhydroxyalkanoate (PHA) polymers and copolymers. The drug delivery systems may be used to deliver pharmacologically active substances, for example, directly from a cochlear implant to the inner ear. The coatings can impart lubricity to cochlear devices for ease of insertion of the electrodes. In the preferred embodiment, the drug delivery system comprises a polyhydroxyalkanoate polymer, and in the most preferred embodiment, the PHA polymer comprises poly(4-hydroxybutyrate) (P(4HB)) or copolymer thereof. A particularly preferred embodiment is where the silicone sheath of the cochlear implant electrodes has been surface modified, and coated with P(4HB), and the P(4HB) either contains a pharmacologically active substance or has been coated with such a substance.

Abstract: An implantable electrode arrangement for an ear implant system is described. A proximal electrode lead has electrode wires for carrying one or more electrical stimulation signals. A distal electrode array has electrode contacts each forming a terminal end of an electrode wire for applying the electrical stimulation signals to target neural tissue, and one or more intra-operative sensors for generating insertion sensing signals during surgical insertion of the electrode array into the target tissue. An intra-operative electrode section has a sensor connector for providing a temporary connection of one or more external measurement arrangements to the one or more intra-operative sensors during the surgical insertion of the electrode array without being functional after the surgical insertion.

Abstract: A device for adjusting and fixing relative position between an actuator end piece of an active hearing implant and an element of the ossicular chain or a coupling part to the human inner ear has a connecting element with a first coupling element for coupling to the actuator end piece, a second coupling element, and a shaft-shaped middle part, and the first coupling element geometrically encompasses the actuator end piece with two opposing parallel arms each having a pattern element to fix the encompassed actuator end piece in selectable discrete axial positions in a direction parallel to an axis of the shaft-shaped middle part, for variable-length adaptation and fixing of the actuator end piece relative to the first coupling element in a direction transverse to the axis.

Abstract: The invention relates to a hearing aid device for humans with impaired hearing, who have an at least partially functional cochlea and a functional nervous signalling pathway from the cochlea via the auditory nerve to the brain. The hearing aid device contains a receiver, a transducer of the sound or other acoustic signals into electrical current serving as a signal representing a sound, a pulsed irradiation source connected to the transducer for receiving the electrical current and for generating modulated pulsed irradiation in dependence from the electrical current, and preferably one or more optical fibres optically coupled to the exit of the pulsed irradiation source, wherein the optical path for conduction of irradiation within the device ends directly opposite a functional element of the natural vibration transduction pathway, e.g.

Abstract: An ossicular prosthesis is described which includes an elongated prosthesis member having a proximal end and a distal end. A cochlea striker mass is at the distal end of the prosthesis member and includes an outer striking surface for coupling vibration of the striker mass to an outer cochlea surface of a recipient patient. A locking clamp is at the proximal end of the prosthesis member and includes a clamp strap having a fixed end and a free end, and a locking head at the fixed end of the clamp strap which has a strap opening for insertion of the free end of the clamp strap. The clamp strap passes around an ossicle of the middle ear in a closed loop and is fixedly engaged by the locking head such that acoustic vibration of the ossicle is coupled by the prosthesis member to the cochlea surface.

Abstract: The present invention provides an apparatus for insertion of a flexible implant into a body section of an implant recipient, the apparatus comprising an elongate guiding section having a longitudinal axis and an inner volume for removably receiving the implant, an elongate first receiving member connected at its first end to a first actuator arranged for moving the first receiving member within the guiding section in parallel to the axis of the guiding section, a first control device for controlling the actuation of the first actuator, wherein first receiving member at its second end opposite its first end carries a gripping unit for releasably gripping a proximal end of the implant, a second actuator for controlling the configuration of the implant, and a second control device for controlling the actuation of the second actuator.

Abstract: An ossicular prosthesis is described which includes an elongated prosthesis member having a proximal end and a distal end. A cochlea striker mass is at the distal end of the prosthesis member and includes an outer striking surface for coupling vibration of the striker mass to an outer cochlea surface of a recipient patient. A locking clamp is at the proximal end of the prosthesis member and includes a clamp strap having a fixed end and a free end, and a locking head at the fixed end of the clamp strap which has a strap opening for insertion of the free end of the clamp strap. The clamp strap passes around an ossicle of the middle ear in a closed loop and is fixedly engaged by the locking head such that acoustic vibration of the ossicle is coupled by the prosthesis member to the cochlea surface.

Abstract: The present invention is directed to a biologically active device with a main body made from a polymer, in which bioactive nanoparticles of one or several materials are embedded, wherein the nanoparticles of at least one material proliferatively act on a biological material contacted by the device, and wherein nanoparticles of a different material act in an anti-proliferative manner on biological material in the ambience of the device. The invention is also directed to a method of manufacturing a biologically active device with a main body made from a polymer, wherein nanoparticles of several different materials are dispersed in an injection-moldable fluid, and the fluid is shaped into the polymer main body by means of injection molding and curing, such that the nanoparticles are dispersed in the bulk of the polymer main body.

Abstract: An electrode array that is implantable within the inferior colliculus of the midbrain and/or other appropriate regions of the brain of an implantee and adapted to provide electrical stimulation thereto. The electrode array an elongate member having a plurality of electrodes mounted thereon in a longitudinal array. A delivery cannula for delivering the electrode array comprised of two half-pipes is also described.

Abstract: The invention provides a cochlea stimulator for implantation comprising optical fibres of which are coupled to an irradiation source that is controlled by a modulator to generate irradiation specific for a pre-determined range of sound-frequencies. The cochlea stimulator effects a frequency-specific activation of the organ of Corti needed for speech perception especially in noisy environment and more complex sounds. For imparting excitation signals which are generated by modulated pulsed laser irradiation conducted within an optical fibre in order to elicit nervous signals in residual functional organ of Corti sections, the auditory prosthesis preferably contains optical fibres which are dimensioned to terminate in end sections within the cochlea at different sites or sections of the organ of Corti. e.g. having different lengths for locating their end sections at different internal parts of the cochlea.

Abstract: The invention relates to a hearing aid device for humans with impaired hearing, who have an at least partially functional cochlea and a functional nervous signalling pathway from the cochlea via the auditory nerve to the brain. The hearing aid device contains a receiver, a transducer of the sound or other acoustic signals into electrical current serving as a signal representing a sound, a pulsed irradiation source connected to the transducer for receiving the electrical current and for generating modulated pulsed irradiation in dependence from the electrical current, and preferably one or more optical fibres optically coupled to the exit of the pulsed irradiation source, wherein the optical path for conduction of irradiation within the device ends directly opposite a functional element of the natural vibration transduction pathway, e.g.

Abstract: An implantable tissue-stimulating device for an implantee. The device comprising an elongate member having at least one electrode. At least a portion of the surface of the elongate member having a configuration that at least partially controls any tissue growth on and/or round the elongate member.

Abstract: A mechanical stimulator for evoking a hearing percept by directly generating waves of fluid motion of fluid in a recipient's scala tympani. The stimulator comprises a sound processing unit configured to process a received sound signal; and an implantable stimulation arrangement, comprising: an actuator configured to receive electrical signals representing the processed sound signal and configured to vibrate in response to the electrical signals, a stapes prosthesis having first and second ends, the first end having a surface configured to be positioned abutting the round window in the recipient's cochlea, and wherein the first end surface is substantially orthogonal to a longitudinal axis extending through the actuator, an elongate rod extending longitudinally from the actuator connecting the actuator to the stapes prosthesis such that vibration of the actuator results in waves of fluid motion in a recipient's scala tympani that evoke a hearing percept of the received sound signal.

Abstract: The present invention provides an apparatus for insertion of a flexible implant into a body section of an implant recipient, the apparatus comprising an elongate guiding section having a longitudinal axis and an inner volume for removably receiving the implant, an elongate first receiving member connected at its first end to a first actuator arranged for moving the first receiving member within the guiding section in parallel to the axis of the guiding section, a first control device for controlling the actuation of the first actuator, wherein first receiving member at its second end opposite its first end carries a gripping unit for releasably gripping a proximal end of the implant, a second actuator for controlling the configuration of the implant, and a second control device for controlling the actuation of the second actuator.

Abstract: An elongate carrier member configured for implantation into a cochlea, the carrier member having a proximal end adapted to be positioned in a basal region of the cochlea, and a distal end adapted to be positioned in an apical region of the cochlea; and a plurality of electrodes disposed at the distal end of the carrier member; wherein the carrier member has a length such that the carrier member cannot be implanted in the cochlea beyond a maximum insertion depth at which residual hearing of the apical region of the cochlea is substantially preserved and at which said carrier member provides electrical-only stimulation to a depth in the cochlea of approximately 270° to 320°. In one embodiment, the carrier member has a length such that the carrier member has a maximum insertion depth into the cochlea of between approximately 14 mm and 18 mm.